Quantitative Analysis of 99mTc-DMSA During Acute Pyelonephritis for Prediction of Long-term Renal Scarring
Overview
Authors
Affiliations
Unlabelled: This study was performed to evaluate a quantitative method based on (99m)Tc-DMSA renal planar scintigraphy performed during acute pyelonephritis (APN) to detect kidneys at risk of scarring.
Methods: A total of 43 children (5.8 +/- 3.6 y old [mean +/- SD]) were examined by (99m)Tc-DMSA scintigraphy during (DMSA 1) and 8 +/- 2 mo after (DMSA 2) APN. Two levels of interpretation were performed independently: first, a semiquantitative analysis to classify the kidneys by considering the evolution between DMSA 1 and DMSA 2 (i.e., to determine which kidneys had developed scarring), and second, an automatic quantitative analysis of DMSA 1 to define and to evaluate a predictive index for kidney evolution from DMSA 1 to DMAS 2. The method consisted of determining an automatic threshold for the kidney and then calculating ratios of the count density in a given isocount n% (region of interest containing all the pixels with a value > or = n% of the value of the pixel with the maximal activity value) to the count density in a 20% isocount (C(n%)) and the number of pixels in a given isocount to the number of pixels in a 20% isocount (S(n%)).
Results: All kidneys normal at DMSA 1 remained normal at DMSA 2. For the automatic index, the C(70%) ratio was considered the best index for the prediction of scarring. When this C(70%) ratio was used, a cutoff value of 0.45 was able to predict scarring with a sensitivity of 0.83, a specificity of 0.78, a positive predictive value of 0.85, and a negative predictive value of 0.77.
Conclusion: A cutoff value of 0.45 for the C(70%) ratio calculated for (99m)Tc-DMSA scintigraphy performed during APN may be useful for detecting kidneys at risk of scarring.
Lu R, Sun F, Zhang L, Zhang C, Du J, Hao J Quant Imaging Med Surg. 2024; 14(1):958-971.
PMID: 38223077 PMC: 10784053. DOI: 10.21037/qims-23-1010.
Non-invasive molecular imaging of kidney diseases.
Klinkhammer B, Lammers T, Mottaghy F, Kiessling F, Floege J, Boor P Nat Rev Nephrol. 2021; 17(10):688-703.
PMID: 34188207 PMC: 7612034. DOI: 10.1038/s41581-021-00440-4.
Chen M, Yang Y, Yang Q, Zhuang J, Ye X, Zheng W BMC Nephrol. 2021; 22(1):181.
PMID: 34001037 PMC: 8130442. DOI: 10.1186/s12882-021-02390-2.
Mapping COVID-19 functional sequelae: the perspective of nuclear medicine.
Brandao S, Ramos J, de Arruda G, Godoi E, Carreira L, Lopes R Am J Nucl Med Mol Imaging. 2020; 10(6):319-333.
PMID: 33329934 PMC: 7724276.
Zhu H, Chen M, Luo H, Pan Y, Zheng W, Yang Y Transl Pediatr. 2020; 9(4):487-495.
PMID: 32953546 PMC: 7475307. DOI: 10.21037/tp-20-59.